GlassScriptPhysician profile
Scott R Mcright
NPI 1568605004
$12,097.84
in general payments reported to CMS, 2019-2025
51 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $1,101 · 2021: $1,907 · 2022: $2,422 · 2023: $2,399 · 2024: $1,840 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,799.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $2,905.19 | 2019-2025 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $783.26 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $769.07 | 2021-2025 | |
| Pfizer INC. | $730.33 | 2019-2025 | |
| Novo Nordisk INC | $690.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $600.59 | 2019-2025 | Mounjaro, Zepbound |
| Acadia Pharmaceuticals INC | $558.35 | 2019-2024 | Nuplazid |
| Glaxosmithkline, LLC. | $434.05 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $423.16 | 2019-2025 | Evenity, Krystexxa, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $384.99 | 2019-2025 | Trintellix |
| Axsome Therapeutics, INC. | $312.99 | 2022-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $285.95 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $284.55 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Otsuka America Pharmaceutical, INC. | $251.86 | 2023-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.45 | 2021-2025 | Jardiance |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $199.26 | 2021-2024 | Nexletol, Nexlizet |
| Lundbeck LLC | $174.17 | 2023-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $160.23 | 2024-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $154.47 | 2019-2021 | |
| Allergan, INC. | $153.13 | 2019-2020 | |
| Dexcom, INC. | $132.75 | 2024-2025 | Dexcom G6 Transmitter |
| Evoke Pharma, INC. | $125.00 | 2023 | Gimoti |
| Sanofi-Aventis U.S. LLC | $124.38 | 2019-2022 | |
| Astellas Pharma US INC | $115.15 | 2019-2025 | Veozah, Myrbetriq |
| Kowa Pharmaceuticals America, INC. | $105.07 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $93.47 | 2022 | |
| Eisai INC. | $85.42 | 2020-2023 | |
| Paratek Pharmaceuticals, INC. | $78.99 | 2022 | |
| Abbott Laboratories | $62.37 | 2022-2023 | Freestyle Libre 3 |
| Corcept Therapeutics | $62.07 | 2025 | Korlym |
| Shield Therapeutics INC | $59.28 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.78 | 2021-2025 | Eliquis, Camzyos |
| Phathom Pharmaceuticals, INC. | $45.31 | 2024-2025 | Voquezna |
| Abiomed | $41.86 | 2025 | |
| Exact Sciences Corporation | $39.56 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $39.50 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $39.09 | 2021 | |
| Avanir Pharmaceuticals, INC. | $35.86 | 2019 | |
| Vifor Pharma, INC. | $34.93 | 2022 | |
| Idorsia Pharmaceuticals US INC | $34.70 | 2022-2023 | Quviviq |
| Itamar Medical INC | $34.30 | 2023 | Watchpatone |
| Alexion Pharmaceuticals, INC. | $28.28 | 2025 | Koselugo |
| Novartis Pharmaceuticals Corporation | $27.98 | 2022-2023 | |
| Pharmacosmos Therapeutics INC. | $24.57 | 2024 | Monoferric |
| Ethicon US, LLC | $17.84 | 2021 | |
| Mallinckrodt Hospital Products INC. | $15.87 | 2023 | Terlivaz |
| Inogen, INC. | $15.16 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Arbor Pharmaceuticals, INC. | $14.12 | 2022 | |
| Ibsa Pharma INC. | $14.09 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.83 | 2025 | Gvoke Hypopen |
| Teva Pharmaceuticals USA, INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mcright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.